XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
At-The-Market Offering
Public Offering
Common Stock
Common Stock
At-The-Market Offering
Common Stock
Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
At-The-Market Offering
Additional Paid-in Capital
Public Offering
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 14,567     $ 2     $ 302,655     $ (288,090)
Beginning balance, shares at Dec. 31, 2020       18,787,579            
Exercise of options to purchase common stock 316           316      
Exercise of options to purchase common stock, shares       46,807            
Stock-based compensation 2,273           2,273      
Issuance of common stock upon offering, net of issuance costs     $ 61,868           $ 61,868  
Issuance of common stock upon offering, net of issuance costs, shares           3,162,500        
Issuance costs related to common stock     $ (560)              
Net loss (10,308)                 (10,308)
Ending balance at Mar. 31, 2021 68,716     $ 2     367,112     (298,398)
Ending balance, shares at Mar. 31, 2021       21,996,886            
Beginning balance at Dec. 31, 2020 14,567     $ 2     302,655     (288,090)
Beginning balance, shares at Dec. 31, 2020       18,787,579            
Net loss (32,117)                  
Ending balance at Jun. 30, 2021 51,864     $ 2     372,069     (320,207)
Ending balance, shares at Jun. 30, 2021       22,272,975            
Beginning balance at Mar. 31, 2021 68,716     $ 2     367,112     (298,398)
Beginning balance, shares at Mar. 31, 2021       21,996,886            
Exercise of options to purchase common stock 2,454           2,454      
Exercise of options to purchase common stock, shares       276,089            
Stock-based compensation 2,690           2,690      
Issuance costs related to common stock (187)           (187)      
Net loss (21,809)                 (21,809)
Ending balance at Jun. 30, 2021 51,864     $ 2     372,069     (320,207)
Ending balance, shares at Jun. 30, 2021       22,272,975            
Beginning balance at Dec. 31, 2021 53,505     $ 2     378,750     (325,247)
Beginning balance, shares at Dec. 31, 2021       22,383,830            
Stock-based compensation 2,349           2,349      
Issuance of common stock upon offering, net of issuance costs   $ 553           $ 553    
Issuance of common stock upon offering, net of issuance costs, shares         110,037          
Issuance costs related to common stock   (17)                
Net loss (8,028)           0     (8,028)
Ending balance at Mar. 31, 2022 48,379     $ 2     381,652     (333,275)
Ending balance, shares at Mar. 31, 2022       22,493,867            
Beginning balance at Dec. 31, 2021 53,505     $ 2     378,750     (325,247)
Beginning balance, shares at Dec. 31, 2021       22,383,830            
Issuance of common stock upon offering, net of issuance costs   $ 600                
Issuance of common stock upon offering, net of issuance costs, shares   110,037                
Net loss (14,803)                  
Ending balance at Jun. 30, 2022 44,398     $ 2     384,446     (340,050)
Ending balance, shares at Jun. 30, 2022       22,545,531            
Beginning balance at Mar. 31, 2022 48,379     $ 2     381,652     (333,275)
Beginning balance, shares at Mar. 31, 2022       22,493,867            
Common stock issued under Employee Stock Purchase Plan (ESPP) 126           126      
Common stock issued under Employee Stock Purchase Plan (ESPP), shares       51,664            
Stock-based compensation 2,668           2,668      
Net loss (6,775)                 (6,775)
Ending balance at Jun. 30, 2022 $ 44,398     $ 2     $ 384,446     $ (340,050)
Ending balance, shares at Jun. 30, 2022       22,545,531